APPOINTMENT OF MRS. NEHA SARDA AS NON EXECUTIVE INDEPENDENT DIRECTOR OF THE COMPANY
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Beryl Drugs Ltd has received shareholder approval at an EGM held on 11 May 2026 for the regularised appointment of Mrs. Neha Sarda as a Non-Executive Independent Director for a term of 5 years. Mrs. Sarda was originally appointed as an Additional Director (Non-Executive-Independent) on 3 January 2026, and this EGM approval regularises that appointment as required under the Companies Act. She is a qualified Company Secretary with knowledge of corporate law, governance, and compliance. The filing confirms she is not related to any existing Director and meets the independence criteria under Section 149(6) of the Companies Act, 2013 and SEBI LODR Regulations. The appointment is not liable to retire by rotation.
This is a routine governance update with neutral impact. The appointment strengthens the Board's independent oversight capacity but has no direct material impact on stock price or operations.